90 related articles for article (PubMed ID: 28551634)
1. Combination of Radiofrequency Ablation and Glycated Chitosan as Treatment on a Syngeneic Breast Tumor Model.
Chiu HY; Leu JD; Chang CY; Lee YJ; Chen WR
Anticancer Res; 2017 Jun; 37(6):2965-2974. PubMed ID: 28551634
[TBL] [Abstract][Full Text] [Related]
2. Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy.
Ahmed M; Kumar G; Navarro G; Wang Y; Gourevitch S; Moussa MH; Rozenblum N; Levchenko T; Galun E; Torchilin VP; Goldberg SN
PLoS One; 2015; 10(7):e0128910. PubMed ID: 26154425
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of glycated chitosan with high-intensity focused ultrasound on suppression of metastases in a syngeneic breast tumor model.
Chen YL; Wang CY; Yang FY; Wang BS; Chen JY; Lin LT; Leu JD; Chiu SJ; Chen FD; Lee YJ; Chen WR
Cell Death Dis; 2014 Apr; 5(4):e1178. PubMed ID: 24743733
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant.
Chen WR; Korbelik M; Bartels KE; Liu H; Sun J; Nordquist RE
Photochem Photobiol; 2005; 81(1):190-5. PubMed ID: 15535737
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect after radiofrequency ablation of murine hepatoma is augmented by an active variant of CC Chemokine ligand 3/macrophage inflammatory protein-1alpha.
Iida N; Nakamoto Y; Baba T; Nakagawa H; Mizukoshi E; Naito M; Mukaida N; Kaneko S
Cancer Res; 2010 Aug; 70(16):6556-65. PubMed ID: 20663902
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation combined with KS-IL2 immunocytokine (EMD 273066) results in an enhanced antitumor effect against murine colon adenocarcinoma.
Johnson EE; Yamane BH; Buhtoiarov IN; Lum HD; Rakhmilevich AL; Mahvi DM; Gillies SD; Sondel PM
Clin Cancer Res; 2009 Aug; 15(15):4875-84. PubMed ID: 19638464
[TBL] [Abstract][Full Text] [Related]
7. [Radiofrequency ablation inhibits lung metastasis ofbreast cancer in mice].
Deng Z; Zhang W; Han Y; Zhang S
Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):497-500. PubMed ID: 26463324
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory effects of radiofrequency ablation in a breast cancer model.
Todorova VK; Klimberg VS; Hennings L; Kieber-Emmons T; Pashov A
Immunol Invest; 2010; 39(1):74-92. PubMed ID: 20064086
[TBL] [Abstract][Full Text] [Related]
9. Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats.
Chen WR; Liu H; Ritchey JW; Bartels KE; Lucroy MD; Nordquist RE
Cancer Res; 2002 Aug; 62(15):4295-9. PubMed ID: 12154032
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice.
Kim EJ; Hong JE; Eom SJ; Lee JY; Park JH
Breast Cancer Res Treat; 2011 Nov; 130(1):61-71. PubMed ID: 21170677
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer metastasis: the DNA repair inhibitor Dbait increases sensitivity to hyperthermia and improves efficacy of radiofrequency ablation.
Devun F; Biau J; Huerre M; Croset A; Sun JS; Denys A; Dutreix M
Radiology; 2014 Mar; 270(3):736-46. PubMed ID: 24475822
[TBL] [Abstract][Full Text] [Related]
12. Propionibacterium acnes Augments Antitumor, Anti-Angiogenesis and Immunomodulatory Effects of Melatonin on Breast Cancer Implanted in Mice.
Talib WH; Saleh S
PLoS One; 2015; 10(4):e0124384. PubMed ID: 25919398
[TBL] [Abstract][Full Text] [Related]
13. Immunostimulatory properties of glycated chitosan.
Zhou F; Song S; Chen WR; Xing D
J Xray Sci Technol; 2011; 19(2):285-92. PubMed ID: 21606589
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis.
Habibi M; Kmieciak M; Graham L; Morales JK; Bear HD; Manjili MH
Breast Cancer Res Treat; 2009 Apr; 114(3):423-31. PubMed ID: 18425677
[TBL] [Abstract][Full Text] [Related]
15. PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor.
Shi L; Chen L; Wu C; Zhu Y; Xu B; Zheng X; Sun M; Wen W; Dai X; Yang M; Lv Q; Lu B; Jiang J
Clin Cancer Res; 2016 Mar; 22(5):1173-1184. PubMed ID: 26933175
[TBL] [Abstract][Full Text] [Related]
16. Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo.
Farsam V; Hassan ZM; Zavaran-Hosseini A; Noori S; Mahdavi M; Ranjbar M
Int Immunopharmacol; 2011 Nov; 11(11):1802-8. PubMed ID: 21824530
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with carboplatin and thalidomide suppresses tumor growth and metastasis in 4T1 murine breast cancer model.
de Souza CM; Araújo e Silva AC; de Jesus Ferraciolli C; Moreira GV; Campos LC; dos Reis DC; Lopes MT; Ferreira MA; Andrade SP; Cassali GD
Biomed Pharmacother; 2014 Feb; 68(1):51-7. PubMed ID: 24054045
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation and immunostimulant OK-432: combination therapy enhances systemic antitumor immunity for treatment of VX2 lung tumors in rabbits.
Hamamoto S; Okuma T; Yamamoto A; Kageyama K; Takeshita T; Sakai Y; Nishida N; Matsuoka T; Miki Y
Radiology; 2013 May; 267(2):405-13. PubMed ID: 23440322
[TBL] [Abstract][Full Text] [Related]
19. In vivo anticancer synergy mechanism of doxorubicin and verapamil combination treatment is impaired in BALB/c mice with metastatic breast cancer.
McCarthy M; Auda G; Agrawal S; Taylor A; Backstrom Z; Mondal D; Moroz K; Dash S
Exp Mol Pathol; 2014 Aug; 97(1):6-15. PubMed ID: 24780744
[TBL] [Abstract][Full Text] [Related]
20. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
